KRAS mutations in cell-free DNA from preoperative and postoperative sera as a pancreatic cancer marker: a retrospective study

[1]  I. Bièche,et al.  Circulating tumor cells and circulating tumor DNA: What surgical oncologists need to know? , 2017, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[2]  Zhou Yuan,et al.  Circulating Tumor Cells and Circulating Tumor DNA Provide New Insights into Pancreatic Cancer , 2016, International journal of medical sciences.

[3]  Ji-Youn Han,et al.  PNA clamping-assisted fluorescence melting curve analysis for detecting EGFR and KRAS mutations in the circulating tumor DNA of patients with advanced non-small cell lung cancer , 2016, BMC Cancer.

[4]  Ji-Youn Han,et al.  Erratum to: PNA clamping-assisted fluorescence melting curve analysis for detecting EGFR and KRAS mutations in the circulating tumor DNA of patients with advanced non-small cell lung cancer , 2016, BMC Cancer.

[5]  Weimin Cai,et al.  K-Ras mutation detection in liquid biopsy and tumor tissue as prognostic biomarker in patients with pancreatic cancer: a systematic review with meta-analysis , 2016, Medical Oncology.

[6]  H. Ueno,et al.  Clinical utility of circulating tumor DNA for molecular assessment in pancreatic cancer , 2015, Scientific Reports.

[7]  N. Malats,et al.  Circulating tumor cells (CTC) and KRAS mutant circulating free DNA (cfDNA) detection in peripheral blood as biomarkers in patients diagnosed with exocrine pancreatic cancer , 2015, BMC Cancer.

[8]  Y. Abe,et al.  Two Cases of Pathological Complete Response to Neoadjuvant Chemoradiation Therapy in Pancreatic Cancer. , 2015, The Keio journal of medicine.

[9]  J. Jacob,et al.  Reduced dissemination of circulating tumor cells with no-touch isolation surgical technique in patients with pancreatic cancer. , 2014, JAMA surgery.

[10]  Klaus Pantel,et al.  Cell-free nucleic acids as biomarkers in cancer patients , 2011, Nature Reviews Cancer.

[11]  M. Ueda,et al.  Beneficial Effects of 5-Fluorouracil and Heparin-Based Portal Infusion Chemotherapy Combined with Mitomycin C and Cisplatin after Curative Resection of Pancreatic Cancer , 2010, Pancreatology.

[12]  M. Hirota,et al.  Pancreatoduodenectomy using a no-touch isolation technique. , 2010, American journal of surgery.

[13]  D. Morton,et al.  mRNA expression and BRAF mutation in circulating melanoma cells isolated from peripheral blood with high molecular weight melanoma-associated antigen-specific monoclonal antibody beads. , 2009, Clinical chemistry.

[14]  S. O’Day,et al.  Utility of Circulating B-RAF DNA Mutation in Serum for Monitoring Melanoma Patients Receiving Biochemotherapy , 2007, Clinical Cancer Research.

[15]  S. Dry,et al.  Unfavourable prognosis associated with K-ras gene mutation in pancreatic cancer surgical margins , 2006, Gut.

[16]  S. O’Day,et al.  Predictive utility of circulating methylated DNA in serum of melanoma patients receiving biochemotherapy. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  M. Ogawa,et al.  Pancreatectomy using the no-touch isolation technique followed by extensive intraoperative peritoneal lavage to prevent cancer cell dissemination: a pilot study. , 2005, JOP : Journal of the pancreas.

[18]  Jonathan W. Uhr,et al.  Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases , 2004, Clinical Cancer Research.

[19]  R. Turner,et al.  Peptide nucleic acid clamp PCR: A novel K‐ras mutation detection assay for colorectal cancer micrometastases in lymph nodes , 2004, International journal of cancer.

[20]  M. Kitago,et al.  Comparison of K‐ras point mutation distributions in intraductal papillary‐mucinous tumors and ductal adenocarcinoma of the pancreas , 2004, International journal of cancer.

[21]  M. Kitajima,et al.  Treatment Strategy for Pancreatic Head Cancer: Pylorus-Preserving Pancreatoduodenectomy, Intraoperative Radiotherapy and Portal Catheterization , 1999, Digestion.

[22]  A. Jemal,et al.  Cancer statistics, 2016 , 2016, CA: a cancer journal for clinicians.

[23]  Y. Hayashizaki,et al.  Usefulness of peptide nucleic acid (PNA)-clamp smart amplification process version 2 (SmartAmp2) for clinical diagnosis of KRAS codon 12 mutations in lung adenocarcinoma: comparison of PNA-clamp SmartAmp2 and PCR-related methods. , 2010, The Journal of molecular diagnostics : JMD.

[24]  S. Goodman,et al.  Circulating mutant DNA to assess tumor dynamics , 2008, Nature Medicine.

[25]  日本膵臓学会.  Classification of pancreatic carcinoma , 2003 .

[26]  Y. Lo,et al.  Rapid clearance of fetal DNA from maternal plasma. , 1999, American journal of human genetics.

[27]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.